1. Drugs for Neoplasia 37

2.  Characterized by rapid, uncontrolled growth of cells  Cells lose normal functions and invade normal tissues  Metastasize: travel to another location (Section 37.1 pg. 542)

3.  Named from tissue of origin

5. Figure 37.1 Invasion and metastasis by cancer cells

8. Encourage clients to adopt healthy lifestyle habits. – Eliminate use and exposure to tobacco – Limit alcohol use – Reduce animal fats in diet – Choose most foods from plant sources – Increase plant fiber in diet – Exercise regularly; keep weight normal – Use protection from sun

9.  Self-examine body monthly for abnormal lumps and skin lesions.  Get periodic screenings: mammogram, prostate exam, fecal occult blood test, colonoscopy, Pap test, pelvic exam.

11.  Surgery  Radiation therapy Three general goals  Drug therapy (chemotherapy)  To cure  For palliation  For prophylaxis

12.  Performed to remove tumor  When localized  When pressing on nerves, airways, or other vital tissues  Radiation and drug therapy more successful

13.  Surgery sometimes not an option  If tumors affect blood cells  If surgery would not extend lifespan or improve quality of life

14.  Can destroy tumor cells  Ionizing radiation aimed directly at tumor  May follow surgery  Used as palliation for inoperable cancers  Shrinks size of tumor  Relieves pain, difficulty breathing or swallowing

15.  Transported through blood  Has potential to reach each cancer cell  Some drugs can cross blood-brain barrier  Some drugs distilled directly into body cavities (ex: bladder)  Often combined with or done after surgery and radiation to increase chance of cure  Called adjuvant therapy

17.  Measure of how many cells are undergoing mitosis  Ratio of replicating cells to resting cells  Major factor in determining success of chemotherapy  Chemotherapy is most effective against rapidly dividing cells  High growth fraction 5 many replicating cells

18.  Solid tumors have low growth fraction; thus less sensitive to chemotherapy  Leukemias and lymphomas have high growth fraction; thus chemotherapy more effective  Hair follicles, bone marrow, gastrointestinal tissue have high growth factor—this explains many adverse effects

19.  Difficult to kill cancer cells without killing normal cells  Adverse effects of therapy  Alopecia  Mucositis (severe nausea, vomiting, diarrhea)  Drugs with high emetic potential pretreated with antiemetics (Compazine, Reglan, Ativan)

20.  Every malignant cell must be removed or killed  Even one cell could reproduce  Immune system eliminates very small number of cancer cells  Important to diagnose cancer early  Treat with surgery, radiation, chemotherapy

21.  Multiple drugs from different classes  Affect different stages in cell cycle  Use different mechanisms of action to increase cell kill  Combinations allow for lower doses  Reduce toxicity  Slow development of resistance

22. Figure 37.3 Cell kill and chemotherapy

23.  Monitor client’s condition  Provide client education  Obtain medical, surgical, drug history  Assess lifestyle and dietary habits.  Obtain description of symptomology and current therapies

24.  Specific dosing protocols  Depend on type of tumor, stage of disease, overall condition of client  Given as single dose or several doses  May be given within days or after several weeks  Gives normal cells chance to recover

25.  Sometimes optimum dose must be delayed  Lets client recover from drug toxicities  Example: in case of bone-marrow depression

26.  Adverse effects of therapy  Bone-marrow depression (anemia, leukopenia, thrombocytopenia)  Treated with bone-marrow transplantation, platelet infusions, or growth factors  If absolute neutrophil count (ANC) falls below 500 mm 3, infection risk grows

27.  Vesicants (antieoplastics given IV)  Can cause tissue injury (extravasation)  Know emergency treatment before giving vesicants IV

28.  Long-term consequences  Possible infertility  Increased risk for secondary tumors

30.  Assessment  Obtain complete health history, including lab values  Platelets, hematocrit (Hct), leukocyte count  Liver- and kidney-function tests, serum electrolytes

31.  Assessment  Obtain drug history to determine possible drug interactions and allergies  Assess neurological status, including mood and sensory impairment  Assess for history or presence of herpes zoster or chickenpox

32.  Nursing Diagnoses  Risk for infection, related to compromised immune system  Risk for deficient fluid volume, related to decreased platelet count  Imbalanced nutrition, less than body requirements  Activity Intolerance; Fatigue; Anxiety  Impaired Oral Mucus Membranes

33.  Nursing Diagnoses  Impaired skin integrity, related to extravasation  Disturbed body image, related to physical changes as result of drug side effects  Fatigue, related to decreased production of RBCs  Ineffective Therapeutic Regimen Management (related to complex medication regimen and disease treatment)

34.  Nursing Diagnoses  Deficient Knowledge (related to disease process and drug therapy)  Hopelessness; Spiritual Distress  Risk for:Decreased Cardiac Output (related to adverse drug effects); Injury, Falls (related to adverse drug effects or disease)  Caregiver Role Strain

35.  Planning—patient will  Experience  Reduction in tumor mass or decreased progression of abnormal cell growth  Absence of signs and symptoms of concurrent infection  Ability to maintain ADLs).  Be free from, or experience minimal adverse effects.

36.  Planning—patient will  Verbalize an understanding of the drug’s use, adverse effects and required precautions.  Demonstrate proper self-administration of the medication (e.g., dose, timing, when to notify provider).

37.  Implementation  Monitor CBC and temperature  * The patient should not take any antipyretic medication because it masks the symptoms of infection  Collect stool samples for guaiac testing of occult blood  Monitor vital signs, cardiorespiratory and respiratory status  Monitor renal status, urine, intake and output, and daily weight

38.  Implementation  Monitor GI status and nutrition  Administer antiemetics 30–45 minutes prior to antineoplastic administration  Monitor for constipation, presence of pain  Monitor neurological/sensory status, level of consciousness  Monitor genitourinary, hepatic status

39.  Implementation  Monitor for hypersensitivity or other adverse reactions (ototoxicity)  Protect patient from infection  Monitor hair and skin status  Monitor for conjunctivitis

40.  Implementation  Monitor liver-function tests  Administer with caution to clients with diabetes mellitus  Provide for adequate pain medication and rest  Provide emotional support for patient and family

41.  Evaluation – The patient  Experiences  Reduction in tumor mass or  Decreased progression of abnormal cell growth  Absence of signs and symptoms of concurrent infection  Ability to maintain ADLs

42. Evaluation –The patient – Is free from, or experiences minimal adverse effects – Verbalizes an understanding of the drug’s use, adverse effects and required precautions – Demonstrates proper self-administration of the medication (e.g., dose, timing, when to notify provider)